SuicideSURAYANCT03538197
Suicide Re Attempts in Young Adults After First Suicide Attempt : Socio-demographic, Clinical and Biological Correlates
A study testing clinical and biological correlates in people with Suicide, run by Hôpital le Vinatier at 1 site in France.
Trial summary
Suicide is the second leading cause of death among people aged 15 to 24 (WHO, 2014). After a first suicide attempt, the 18 to 25 years old would be very likely to repeat the act: 25 to 31% would make a new attempt in the following year (Christiansen et al, 2007). Read more about this study
- Who is it for?
- Ages 18 to 25 years
- Conditions the study is for
- Suicide
- What is being tested?
- clinical and biological correlates
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteFrance
- Study dates
- 22 May 2018to 29 Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- between the ages of 18 and 25
- a first suicide attempt
- Master French sufficient
Who cannot join
- Majors protected: under curatorship or under guardianship
Trial locations and contacts
1 site in 1 country.
About this study
Official title: SURAYA : Suicide Re Attempts in Young Adults After First Suicide Attempt : Socio-demographic, Clinical and Biological Correlates
Suicide is the second leading cause of death among people aged 15 to 24 (WHO, 2014). After a first suicide attempt, the 18 to 25 years old would be very likely to repeat the act: 25 to 31% would make a new attempt in the following year (Christiansen et al, 2007).
Nevertheless the literature on this subject is not detailed. In this project, we hypothesize that young adults aged 18 to 25 who have made their first suicide attempt will repeat their act more frequently than younger or older populations. In addition, these young people would have identifiable risk factors (sociodemographic, clinical and biological) that differ from young people who do not enter this phenomenon.
Read more
Our main objective is to measure the rate of suicidal reiteration in a population of young adults aged 18 to 25 years.
Our secondary objectives are to identify sociodemographic, clinical and biological characteristics of a population of suicidal re attempt young people, to highlight potential risk factors
Read the detailed description
Objectives:
- Our main objective is to measure the rate of suicidal re attempt (SR) in a population of young adults aged 18 to 25 years.
- Our secondary objectives are to identify sociodemographic, clinical and biological characteristics of a population of suicidal young people, in an attempt to highlight potential risk factors. We will try to highlight correlations between the reiteration of the suicidal act and:
- socio-demographic criteria: level of urbanity, socio-economic level, social and family context, date and place of birth, religion, sexual orientation, name and contact details of the general practitioner, previous access to care
- scores on the scales of various psychiatric pathologies, existing or in formation (eg depression, anxiety disorders, psychosis)
- alterations at the peripheral level
- on the stress response system: cortisolemia and capillary cortisol levels
- on the total and mature serum BDNF
In addition, DNA and RNA genetic samples will be taken in order to constitute a biological collection for later research.
Type of study: This is an interventional research with minimal risks and constraints (2 ° study), multicenter prospective cohort.
Number of centers: 2 Suicide Prevention Center at the Le Vinatier Hospital Center and the Post Crisis Unit at the Edouard Herriot Hospital of the Hospices Civils de Lyon.
Description of the study / experimental plan:
This is a prospective cohort study that will be divided into two groups: "repeat suicide attempt" and "no repeat attempt"
Primary judgment criterion:
This is the occurrence of repeating a suicide attempt (over a period of 3 months after the initial attempt.
In this project, a suicide attempt is defined according to WHO criteria as "non-fatal suicidal behavior, self-inflicted injury with a desire to end one's life that does not lead to death".
Number of subjects:
Our study will include 200 patients at the Le Vinatier CH Suicide Prevention Center and the Post Crisis Unit at Edouard Herriot Hospital.
inclusion criteria: between the ages of 18 and 25
- a first suicide attempt
- Master French sufficient
Exclusion Criteria:
-Majors protected: under curatorship or under guardianship
Course of the study :
-Inclusion will take place immediately after the first suicide attempt at the Post Crisis Unit at Edouard Herriot Hospital and the Suicide Prevention Center.
An anamnestic collection of social and demographic data will be carried out: level of urbanity, professional activity, level of study, access to care, and previous care received, socio-economic level, social and family context (notably existing conflict with parents or love break-up). The patient's telephone number will be collected as well as the patient's psychiatric and addiction history, and the means used for the suicide attempt.
Different scales of assessments, by means of self-questionnaires, will be given to the patient and an investigator will provide the C-SSRS scale assessment for the suicidal risk severity. Finally a venous blood sample will be performed with a measure of total and mature serum BDNF and cortisolemia. Capillary cortisol will also be measured.
After obtaining the patient's consent, two blood samples (DNA and RNA) will be collected and stored at -80 degrees to create a biological collection for later research.
An orientation in the course of care will then be given to the subject who will receive the appropriate care as well as a phone call made by the Suicide Prevention Center.
-At 3 months: A phone call will be made to check the presence or absence of the main evaluation criterion: the repetition of a suicide attempt. In addition, the patient will be asked about life events during these three months and the care received since inclusion.
Benefits and risks of this study:
The expected benefits of this study are: a better understanding of the mechanisms underlying the recurrence of the suicidal act, which could allow an optimal patient management and an adapted orientation in the care network, this for a setting in place in the near future.
In addition, patients included in the study will benefit from follow-up.
The foreseeable risk is the SR that can lead to suicide. To minimize this risk, each patient included in this protocol will benefit from a clinical evaluation performed by a trained investigator. At the end of this evaluation, according to the observed suicidal risk, an orientation in the course of care will be proposed. Each patient will be informed of the different modalities of psychiatry consultations and how to challenge the network. In addition, all patients will receive a phone call from the Suicide Prevention Center.
No serious adverse effects that could be attributed to the project are expected as part of this research.
Indeed, the blood test is carried out systematically as part of a post-suicide treatment and no other invasive examination is scheduled. The only undesirable events that can occur after a venous blood collection are: a hematoma at the point of puncture, pain during the bite, vagal discomfort or rare cases of infectious risks. These risks are greatly minimized by means of sterile single-use equipment and qualified medical personnel, and can not be considered as a serious expected adverse effect.
- Conditions
- Suicide
- Being tested
- clinical and biological correlates
- Keywords
- suicide attempt, suicide re attempt
- Medical subject headings
- Suicide, Suicide, Attempted
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
clinical and biological correlatesOther
To measure the rate of suicidal re attempt (SR) in a population of young adults aged 18 to 25 years.
To identify sociodemographic, clinical and biological characteristics of a population of suicidal young people, in an attempt to highlight potential risk factors
| Study group | Role | What they receive |
|---|---|---|
| SUICID ATTEMPT YOUNG PEOPLE | Other | Suicide Re Attempts in Young Adults after first suicide attempt : socio-demographic, clinical and biological correlates Receives: Other: clinical and biological correlates |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of the prevalence of SR rate over a 3-months period after the first suicide attempt, among young adults aged 18 to 25.
Measured: Within the first 3 months following a first suicide attempt
Secondary outcomes (21)
mature and total BDNF
We will try to highlight correlations between the reiteration of the suicidal act and biological measures
Measured: Within the first 3 months after the first suicide attempt
level of urbanity
sociodemographic risk factor
Measured: Within the first 3 month following a first suicide attempt
socio-economic level
sociodemographic risk factor
Measured: Within the first 3 month following a first suicide attempt
social and family context
sociodemographic risk factor
Measured: Within the first 3 months following a first suicide attempt
date of birth
sociodemographic risk factor
Measured: Within the first 3 months following a first suicide attempt
place of birth
sociodemographic risk factor
Measured: Within the first 3 months following a first suicide attempt
BIS : Barratt Impulsive Scale
The Barratt Impulsiveness Scale (BIS) is a widely used measure of impulsiveness. It includes 30 items that are scored to yield six first-order factors (attention, motor, self-control, cognitive complexity, perseverance, and cognitive instability impulsiveness) and three second-order factors (attentional, motor, and non-planning impulsiveness).
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
C-SSRS : Colombia Suicide Severity Rating Scale
The Screener contains 6 "yes" or "no" questions in which respondents are asked to indicate whether they have experienced several thoughts or feelings relating to suicide over the past month and behaviors over their lifetime and past 3 months. Each question addresses a different component of the respondent's suicide ideation severity and behavior.
Question 1: wish to be dead Question 2: non-specific suicidal thoughts Questions 3-5: more specific suicidal thoughts and intent to act Question 6: suicidal behavior over the respondent's lifetime and past 3 months If the respondent answers "yes" to Question 2, he/she is instructed to answer Questions 3-5. If the respondent answers "no" to Question 2, he/she may skip to Question 6.
An answer of "yes" to any of the six questions may indicate a need for referral to a trained mental health professional and an answer of "yes" to questions 4, 5 or 6 indicate high-risk.
Measured: Within the first 3 months following a first suicide attempt
hair cortisol and blood cortisol
We will try to highlight correlations between the reiteration of the suicidal act and biological measures
Measured: Within the first 3 months following a first suicide attempt
Analog visual scales
The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
Negative life events during the last 6 months
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
The reasons for living inventory
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
CTQ : childhood trauma questionnary
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
STAXI-2
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
PQB : psychosis risk screening
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
QIDS : Quick Inventory of Depressive Symptomatology
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
MDQ : Mood disorder questionnaire
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
CUDIT : Cannabis use Disorders Identification Test
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
CAST : Cannabis Abuse Screening Test
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
Fagerstrom Questionary
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
AUDIT : Alcohol use disorders test
Clinical risk factor : We aim to highlight correlations between the reiteration of the suicidal act and different scores on clinical scales
Measured: Within the first 3 months following a first suicide attempt
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 May 2018
- Study start22 May 2018
- Primary completion29 Jun 2022
- Study completion29 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SuicideStudies of the same condition, open and under way.
- More trials run by Hôpital le VinatierThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Cohort study
- Masking
- None (open label)
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hôpital le Vinatier
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- POULET Emmanuel, Ph, Principal investigator, CH LE VINATIER
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03538197
- Sponsor's protocol ID
- 2017-A03129-44
- Acronym
- SURAYA
- Status last verified
- Sep 2024
- First submitted
- 16 Apr 2018
- Last updated
- 19 Sep 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Abrial E, Chalancon B, Leaune E, Brunelin J, Wallon M, Moll F, Barakat N, Hoestlandt B, Fourier A, Simon L, Magnin C, Hermand M, Poulet E. Investigating Predictive Factors of Suicidal Re-attempts in Adolescents and Young Adults After a First Suicide Attempt, a Prospective Cohort Study. Study Protocol of the SURAYA Project. Front Psychiatry. 2022 Jun 29;13:916640. doi: 10.3389/fpsyt.2022.916640. eCollection 2022.
PubMed 35845461
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- SURAYA : Suicide Re Attempts in Young Adults After First Suicide Attempt : Socio-demographic, Clinical and Biological Correlates
- ClinicalTrials.gov ID
- NCT03538197
- Acronym / sponsor ID
- SURAYA / 2017-A03129-44
- Conditions
- Suicide
- Keywords
- suicide attempt, suicide re attempt
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Hôpital le VinatierUniversity, hospital or other
- Study start
- 22 May 2018 (actual)
- Primary completion
- 29 Jun 2022 (actual)
- Study completion
- 29 Jun 2022 (actual)
- First posted
- 29 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Suicide is the second leading cause of death among people aged 15 to 24 (WHO, 2014). After a first suicide attempt, the 18 to 25 years old would be very likely to repeat the act: 25 to 31% would make a new attempt in the following year (Christiansen et al, 2007).
Nevertheless the literature on this subject is not detailed. In this project, we hypothesize that young adults aged 18 to 25 who have made their first suicide attempt will repeat their act more frequently than younger or older populations. In addition, these young people would have identifiable risk factors (sociodemographic, clinical and biological) that differ from young people who do not enter this phenomenon.
Our main objective is to measure the rate of suicidal reiteration in a population of young adults aged 18 to 25 years.
Our secondary objectives are to identify sociodemographic, clinical and biological characteristics of a population of suicidal re attempt young people, to highlight potential risk factors
Detailed description
Objectives:
- Our main objective is to measure the rate of suicidal re attempt (SR) in a population of young adults aged 18 to 25 years.
- Our secondary objectives are to identify sociodemographic, clinical and biological characteristics of a population of suicidal young people, in an attempt to highlight potential risk factors. We will try to highlight correlations between the reiteration of the suicidal act and:
- socio-demographic criteria: level of urbanity, socio-economic level, social and family context, date and place of birth, religion, sexual orientation, name and contact details of the general practitioner, previous access to care
- scores on the scales of various psychiatric pathologies, existing or in formation (eg depression, anxiety disorders, psychosis)
- alterations at the peripheral level
- on the stress response system: cortisolemia and capillary cortisol levels
- on the total and mature serum BDNF
In addition, DNA and RNA genetic samples will be taken in order to constitute a biological collection for later research.
Type of study: This is an interventional research with minimal risks and constraints (2 ° study), multicenter prospective cohort.
Number of centers: 2 Suicide Prevention Center at the Le Vinatier Hospital Center and the Post Crisis Unit at the Edouard Herriot Hospital of the Hospices Civils de Lyon.
Description of the study / experimental plan:
This is a prospective cohort study that will be divided into two groups: "repeat suicide attempt" and "no repeat attempt"
Primary judgment criterion:
This is the occurrence of repeating a suicide attempt (over a period of 3 months after the initial attempt.
In this project, a suicide attempt is defined according to WHO criteria as "non-fatal suicidal behavior, self-inflicted injury with a desire to end one's life that does not lead to death".
Number of subjects:
Our study will include 200 patients at the Le Vinatier CH Suicide Prevention Center and the Post Crisis Unit at Edouard Herriot Hospital.
inclusion criteria: between the ages of 18 and 25
- a first suicide attempt
- Master French sufficient
Exclusion Criteria:
-Majors protected: under curatorship or under guardianship
Course of the study :
-Inclusion will take place immediately after the first suicide attempt at the Post Crisis Unit at Edouard Herriot Hospital and the Suicide Prevention Center.
An anamnestic collection of social and demographic data will be carried out: level of urbanity, professional activity, level of study, access to care, and previous care received, socio-economic level, social and family context (notably existing conflict with parents or love break-up). The patient's telephone number will be collected as well as the patient's psychiatric and addiction history, and the means used for the suicide attempt.
Different scales of assessments, by means of self-questionnaires, will be given to the patient and an investigator will provide the C-SSRS scale assessment for the suicidal risk severity. Finally a venous blood sample will be performed with a measure of total and mature serum BDNF and cortisolemia. Capillary cortisol will also be measured.
After obtaining the patient's consent, two blood samples (DNA and RNA) will be collected and stored at -80 degrees to create a biological collection for later research.
An orientation in the course of care will then be given to the subject who will receive the appropriate care as well as a phone call made by the Suicide Prevention Center.
-At 3 months: A phone call will be made to check the presence or absence of the main evaluation criterion: the repetition of a suicide attempt. In addition, the patient will be asked about life events during these three months and the care received since inclusion.
Benefits and risks of this study:
The expected benefits of this study are: a better understanding of the mechanisms underlying the recurrence of the suicidal act, which could allow an optimal patient management and an adapted orientation in the care network, this for a setting in place in the near future.
In addition, patients included in the study will benefit from follow-up.
The foreseeable risk is the SR that can lead to suicide. To minimize this risk, each patient included in this protocol will benefit from a clinical evaluation performed by a trained investigator. At the end of this evaluation, according to the observed suicidal risk, an orientation in the course of care will be proposed. Each patient will be informed of the different modalities of psychiatry consultations and how to challenge the network. In addition, all patients will receive a phone call from the Suicide Prevention Center.
No serious adverse effects that could be attributed to the project are expected as part of this research.
Indeed, the blood test is carried out systematically as part of a post-suicide treatment and no other invasive examination is scheduled. The only undesirable events that can occur after a venous blood collection are: a hematoma at the point of puncture, pain during the bite, vagal discomfort or rare cases of infectious risks. These risks are greatly minimized by means of sterile single-use equipment and qualified medical personnel, and can not be considered as a serious expected adverse effect.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Cohort study
| Arm | Type | Receives |
|---|---|---|
| SUICID ATTEMPT YOUNG PEOPLE | Other | Other: clinical and biological correlatesSuicide Re Attempts in Young Adults after first suicide attempt : socio-demographic, clinical and biological correlates |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- between the ages of 18 and 25
- a first suicide attempt
- Master French sufficient
Key exclusion criteria (1 listed)
- Majors protected: under curatorship or under guardianship
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| clinical and biological correlatesTo measure the rate of suicidal re attempt (SR) in a population of young adults aged 18 to 25 years. To identify sociodemographic, clinical and biological characteristics of a population of suicidal young people, in an attempt to highlight potential risk factors | Other | SUICID ATTEMPT YOUNG PEOPLE |
Primary outcome
Assessment of the prevalence of SR rate over a 3-months period after the first suicide attempt, among young adults aged 18 to 25.
Time frame: Within the first 3 months following a first suicide attempt
21 secondary outcomes
mature and total BDNF
Time frame: Within the first 3 months after the first suicide attempt
level of urbanity
Time frame: Within the first 3 month following a first suicide attempt
socio-economic level
Time frame: Within the first 3 month following a first suicide attempt
social and family context
Time frame: Within the first 3 months following a first suicide attempt
date of birth
Time frame: Within the first 3 months following a first suicide attempt
place of birth
Time frame: Within the first 3 months following a first suicide attempt
BIS : Barratt Impulsive Scale
Time frame: Within the first 3 months following a first suicide attempt
C-SSRS : Colombia Suicide Severity Rating Scale
Time frame: Within the first 3 months following a first suicide attempt
hair cortisol and blood cortisol
Time frame: Within the first 3 months following a first suicide attempt
Analog visual scales
Time frame: Within the first 3 months following a first suicide attempt
Negative life events during the last 6 months
Time frame: Within the first 3 months following a first suicide attempt
The reasons for living inventory
Time frame: Within the first 3 months following a first suicide attempt
CTQ : childhood trauma questionnary
Time frame: Within the first 3 months following a first suicide attempt
STAXI-2
Time frame: Within the first 3 months following a first suicide attempt
PQB : psychosis risk screening
Time frame: Within the first 3 months following a first suicide attempt
QIDS : Quick Inventory of Depressive Symptomatology
Time frame: Within the first 3 months following a first suicide attempt
MDQ : Mood disorder questionnaire
Time frame: Within the first 3 months following a first suicide attempt
CUDIT : Cannabis use Disorders Identification Test
Time frame: Within the first 3 months following a first suicide attempt
CAST : Cannabis Abuse Screening Test
Time frame: Within the first 3 months following a first suicide attempt
Fagerstrom Questionary
Time frame: Within the first 3 months following a first suicide attempt
AUDIT : Alcohol use disorders test
Time frame: Within the first 3 months following a first suicide attempt
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
- Derived from this study: PubMed 35845461Abrial E, Chalancon B, Leaune E, Brunelin J, Wallon M, Moll F, Barakat N, Hoestlandt B, Fourier A, Simon L, Magnin C, Hermand M, Poulet E. Investigating Predictive Factors of Suicidal Re-attempts in Adolescents and Young Adults After a First Suicide Attempt, a Prospective Cohort Study. Study Protocol of the SURAYA Project. Front Psychiatry. 2022 Jun 29;13:916640. doi: 10.3389/fpsyt.2022.916640. eCollection 2022.
- Individual participant dataSharing planned: No
Related trials for Suicide
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
POULET Emmanuel, Ph principal investigator
CH LE VINATIER
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing clinical and biological correlates in people with Suicide, run by Hôpital le Vinatier at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of the prevalence of SR rate over a 3-months period after the first suicide attempt, among young adults aged 18 to 25. (time frame: Within the first 3 months following a first suicide attempt). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03538197, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.